AkzoNobel starts €2.5 billion share buyback on February

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
53
AkzoNobel starts €2.5 billion share buyback on February 25 to be completed by end 2019

February 13, 2019

Akzo Nobel N.V. (AKZA; AKZOD; AKZOY)

AkzoNobel intends to repurchase common shares up to a value of €2.5 billion as part of a total €6.5 billion being distributed to shareholders following the sale of the Specialty Chemicals business.

The share buyback will start on or around February 25, 2019 and is due to be completed by the end of 2019. AkzoNobel will engage a third party to manage the program and execute transactions on its behalf. It is intended that the shares will be cancelled following repurchase.

The share buyback will be executed within the limitations of the authority granted by the Annual General Meeting (AGM) on April 26, 2018 and the authority granted by future AGMs. The share repurchase program will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the safe harbor parameters prescribed by the Commission Delegated Regulation 2016/1052 for share buybacks.

In accordance with regulations, AkzoNobel will inform the market about the progress made in the execution of this program through weekly updates and at https://www.akzonobel.com/for-investors/share...k-overview

About AkzoNobel AkzoNobel has a passion for paint. We're experts in the proud craft of making paints and coatings, setting the standard in color and protection since 1792. Our world class portfolio of brands - including Dulux, International, Sikkens and Interpon - is trusted by customers around the globe. Headquartered in the Netherlands, we are active in over 150 countries and employ around 34,500 talented people who are passionate about delivering the high performance products and services our customers expect.

Not for publication - for more information   AkzoNobel Media Relations AkzoNobel Investor Relations
T +31 (0)88 - 969 7833 T +31 (0)88 - 969 7856
Contact: Joost Ruempol Media.relations@akzonobel.com Contact: Lloyd Midwinter Investor.relations@akzonobel.com  

Safe Harbor Statement This press release contains statements which address such key issues such as AkzoNobel's growth strategy, future financial results, market positions, product development, products in the pipeline and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures, as well as the sale of Specialty Chemicals. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business please see our latest annual report, a copy of which can be found on our website: www.akzonobel.com.

Attachment

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Flux Expands AI Platform to Prove Engineering ROI

Updated Category News Views 5

Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...

Continue Reading
RunVermont Revamps City Marathon, Adds Half for 2027

Updated Category News Views 2

Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...

Continue Reading
SureDone's Taska AI: Transforming Marketplace Listings

Updated Category News Views 3

Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...

Continue Reading
Epiclay: Game Changer for Sculptors Debuts

Updated Category News Views 4

Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...

Continue Reading
Foodsmart's Program Links Food Benefits to Health Gains

Updated Category News Views 2

Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...

Continue Reading
Hi-Tech's Dubai Chocolate Adds Flavor to Sales Surge

Updated Category News Views 3

Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...

Continue Reading
IWP and SHARE Forge New Path for Filmmaker Funding

Updated Category News Views 2

Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...

Continue Reading
SACHEU Partners with AI to Harness Real Customer Insights

Updated Category News Views 3

Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...

Continue Reading
Oracle Harnesses AI to Streamline Healthcare Payments

Updated Category News Views 4

Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...

Continue Reading
First Lady Steals NYSE Show, Investors Eye Stakes

Updated Category News Views 2

Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...

Continue Reading

Top 5 Most Recently Viewed Articles

Projected Growth of the Medical Devices Market Exceeds $905 Billion

Updated Category News Views 229

Overview of the Medical Devices Market The global medical devices market is on a promising trajectory, anticipated to exceed US$ 905.56 billion by the year 2033 from a valuation of US$ 517.86 billion in 2024, reflecting a compound annual growth rate (CAGR) of 6.4% throughout the forecast period. This remarkable growth is largely influenced by various factors such as...

Continue Reading
Class Action Lawsuit Update for Agenus Inc. (NASDAQ: AGEN)

Updated Category News Views 37

Agenus Inc. Faces Class Action Lawsuit: Key Details for Investors Investors in Agenus Inc. are currently facing critical news regarding a class action securities lawsuit. This legal action has been initiated by Levi & Korsinsky, LLP, a firm that specializes in representing investors in cases related to securities litigation. The company, identified by the stock ticker...

Continue Reading
G6 Networks Unveils GSX Token, Paving the Way for Blockchain Innovation

Updated Category News Views 90

G6 Networks Unleashes GSX Token for Blockchain Transformation G6 Networks has made a remarkable advancement in the blockchain sector with the launch of its GSX token. This initiative promises to pave the way for greater transparency and accessibility within the blockchain community. Offered at a competitive price of $0.85 per token, the three-tier structured launch is...

Continue Reading
Revolutionizing Weight Loss: ASC47 and Semaglutide Study Results

Updated Category News Views 250

ASC47 and Semaglutide: A Promising Combination for Weight Loss Ascletis Pharma Inc. has unveiled exciting findings regarding its weight loss medication, ASC47, particularly when paired with Semaglutide. Participants suffering from obesity showed significantly improved outcomes with this innovative combination therapy, demonstrating a greater reduction in body weight...

Continue Reading
Reviva Pharmaceuticals Secures $10 Million Through Public Offering

Updated Category News Views 187

Reviva Pharmaceuticals Secures Funding for Advancement Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a dedicated late-stage pharmaceutical company, is making significant strides in the development of innovative therapies aimed at addressing critical needs in the realms of central nervous system (CNS), inflammatory, and cardiometabolic diseases. Recently, Reviva...

Continue Reading